Flagship Pioneering related stories
All articles and analysis
TARIS Biomedical Inks $18.3M Series BLexington, Mass.-based TARIS Biomedical, which is developing therapies to treat bladder disease, has raised $18.3 million in Series B financing. New investors Third Rock Ventures led the round, which included participation from existing shareholders Flagship Ventures, Flybridge Capital Partners and Polaris Venture Partners. The company’s prior bridge financing was also converted into equity in connection with the financing round. Third Rock’s Cary Pfeffer will join the TARIS board.
- VC-Backed Acceleron Nabs $1.5M Grant
Acceleron Pharma, which is backed by firms including Advanced Technology Ventures, Bessemer Ventures, Polaris Ventures, Sutter Hill Ventures and Venrock, was awarded a $1.5 million grant from the Muscular Dystrophy Association. The grant will go to support clinical studies of the company’s products.
- Cleantech Start-up LS9 Inks $30 Million Round
South San Francisco, Calif.-based LS9 has raised $30 million in a round of financing led by Blackrock. Existing shareholders Flagship Ventures, Khosla Ventures, Lightspeed Venture Partners and CTTV Investments (the venture capital arm of Chevron Technology Ventures) also participated. The new financing will be used to help LS9 ready its products for commercialization. LS9’s technology is designed to convert plant-based materials into fuel and chemical products. The company was formed in 2005.
- Third Rock’s Hands-On Approach Appeals to LPs
Firm raises $426M in oversubscribed second fund by showing how its company incubation strategy can lead to a quick exit
- LPs love Third Rock's hands-on approach
Firm raises $426M in oversubscribed second fund by showing how its method can lead to a quick exit
- Third Rock Ventures Secures $426M For Fund II
Third Rock Ventures LLC has raised $426 million for a second fund earmarked for life sciences companies. The firm, which raised a debut fund of $378 million back in 2007, also announced several personnel changes, including the promotion of Alexis Borisy from entrepreneur-in-residence to partner.
- Exit watch, week of Aug. 9, 2010
News briefs about Storwize and other VC-backed startups that were acquired in the past week
- PerkinElmer Buys VisEn Medical
PerkinElmer Inc. (NYSE: PKI) has acquired VisEn Medical Inc., a Bedford, Mass.-based developer of fluorescence molecular imaging technology platforms. No financial terms were disclosed. VisEn had raised around $30 million in VC funding from Merck Capital Ventures, Flagship Ventures, Siemens AG Medical Solutions and Spinnaker Capital.